LifeStance Health Group, Inc. (NASDAQ:LFST) Insider Lisa K. Miller Sells 18,845 Shares

LifeStance Health Group, Inc. (NASDAQ:LFST) insider Lisa K. Miller sold 18,845 shares of LifeStance Health Group stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the transaction, the insider now directly owns 339,810 shares in the company, valued at $2,344,689. This trade represents a 5.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

LifeStance Health Group Stock Performance

LifeStance Health Group stock opened at $6.74 on Wednesday. LifeStance Health Group, Inc. has a fifty-two week low of $4.64 and a fifty-two week high of $8.61. The stock has a market cap of $2.59 billion, a price-to-earnings ratio of -25.92 and a beta of 1.27. The stock’s 50 day simple moving average is $7.77 and its two-hundred day simple moving average is $7.35. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Institutional Investors Weigh In On LifeStance Health Group

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Jennison Associates LLC boosted its holdings in shares of LifeStance Health Group by 9.5% during the 3rd quarter. Jennison Associates LLC now owns 2,136,942 shares of the company’s stock valued at $14,959,000 after buying an additional 184,896 shares in the last quarter. Intech Investment Management LLC bought a new stake in LifeStance Health Group during the third quarter worth about $311,000. Landscape Capital Management L.L.C. grew its holdings in LifeStance Health Group by 43.7% in the third quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company’s stock worth $2,576,000 after purchasing an additional 111,894 shares during the period. Charles Schwab Investment Management Inc. increased its stake in shares of LifeStance Health Group by 36.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after purchasing an additional 297,723 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of LifeStance Health Group by 10.5% during the third quarter. The Manufacturers Life Insurance Company now owns 81,741 shares of the company’s stock valued at $572,000 after purchasing an additional 7,798 shares during the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

LFST has been the topic of several analyst reports. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research note on Friday, February 28th. The Goldman Sachs Group raised shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective for the company in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $8.63.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.